The immunopathology of sepsis and potential therapeutic targets

T van der Poll, FL van de Veerdonk… - Nature Reviews …, 2017 - nature.com
Sepsis is defined as a life-threatening organ dysfunction that is caused by a dysregulated
host response to infection. In sepsis, the immune response that is initiated by an invading …

Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome

FL van de Veerdonk, MG Netea, M van Deuren… - Elife, 2020 - elifesciences.org
COVID-19 patients can present with pulmonary edema early in disease. We propose that this
is due to a local vascular problem because of activation of bradykinin 1 receptor (B1R) and …

[PDF][PDF] Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection

…, N Curtis, R van Crevel, FL van de Veerdonk… - Cell, 2020 - cell.com
SARS-CoV-2 infection is mild in the majority of individuals but progresses into severe
pneumonia in a small proportion of patients. The increased susceptibility to severe disease in the …

mTOR-and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity

…, P Willems, FL van de Veerdonk, JWM van Der Meer… - science, 2014 - science.org
Introduction Trained immunity refers to the memory characteristics of the innate immune system.
Memory traits of innate immunity have been reported in plants and invertebrates, as well …

Differential requirement for the activation of the inflammasome for processing and release of IL-1β in monocytes and macrophages

…, FL van de Veerdonk… - Blood, The Journal …, 2009 - ashpublications.org
The processing of pro-interleukin-1β depends on activation of caspase-1. Controversy has
arisen whether Toll-like receptor (TLR) ligands alone can activate caspase-1 for release of …

[HTML][HTML] A minimal common outcome measure set for COVID-19 clinical research

…, A Turgeon, T Uyeki, F van de Veerdonk… - The lancet infectious …, 2020 - thelancet.com
Clinical research is necessary for an effective response to an emerging infectious disease
outbreak. However, research efforts are often hastily organised and done using various …

[HTML][HTML] A guide to immunotherapy for COVID-19

FL van de Veerdonk, E Giamarellos-Bourboulis… - Nature medicine, 2022 - nature.com
Immune dysregulation is an important component of the pathophysiology of COVID-19. A
large body of literature has reported the effect of immune-based therapies in patients with …

Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report

…, WI Sligl, AF Turgeon, AM Turner, FL van de Veerdonk… - Medrxiv, 2021 - medrxiv.org
Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …

Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial

…, C Saunders, C Seymour, A Turner, F van de Veerdonk… - Jama, 2020 - jamanetwork.com
Importance Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19)
is limited. Objective To determine whether hydrocortisone improves outcome for …

Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis

…, A Turner, W van Bentum-Puijk, F van de Veerdonk… - Jama, 2021 - jamanetwork.com
Importance Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …